Tag archive for ‘(Nasdaq: BLRX); TASE:BLRX)’

BioLineRx licenses $30 million deal value for Hepatitis C drug to Chinese CTTQ co

– BioLineRx has signed an agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. (CTTQ) for the development and commercialization of BL-8030, an oral treatment for the Hepatitis C virus More...

Wordpress site Developed by Fixing WordPress Problems